Congenital insensitivity to pain with anhidrosis: A case report and literature review.
10.11817/j.issn.1672-7347.2019.190390
- Author:
Yanying CHEN
1
;
Caixia LONG
1
;
Lan LUO
1
Author Information
1. Emergency Center, Children's Hospital of Hunan Province, Changsha 410007, China.
- Publication Type:Case Reports
- MeSH:
Channelopathies;
Humans;
Infant;
Mutation;
Pain Insensitivity, Congenital;
Receptor, trkA
- From:
Journal of Central South University(Medical Sciences)
2019;44(10):1203-1208
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the clinical manifestations and gene mutations in children with congenital insensitivity to pain with anhidrosis (CIPA), and review related literature. An infant diagnosed with congenital insensitivity to pain with anhidrosis was reported. The main clinical manifestations of the infant were painless, no sweat, and repeated fever. Peripheral blood of the infant and his parents was collected, and candidate variants were confirmed by Sanger sequencing. The results of molecular genetic analysis showed that there were compound heterozygous mutations (c.36G>A, c.851-33T>A) of neurotrophic tyrosine kinase receptor type 1 (NTRK1) in the infant. c.36G>A and c.851-33T>A were inherited from his father and mother, respectively. c.851-33T>A is a previously reported mutation, c.36G>A is an unreported mutation, which can lead to the tryptophan changing into a stop codon. According to the American College of Medical Genetics and Genomics (ACMG) variant interpretation guidelines, the mutation is interpreted as pathogenic, and the biological hazard is potentially harmful. Congenital insensitivity to pain with anhidrosis is a rare inherited disorder. Genetic molecular genetic analysis is helpful to diagnose and discover new gene mutations.
